BR9908765A - Process for the preparation of the tetrapeptide h-tyr-d-ala-phe (f) -phe-nh2, peptide, and peptide derivative - Google Patents

Process for the preparation of the tetrapeptide h-tyr-d-ala-phe (f) -phe-nh2, peptide, and peptide derivative

Info

Publication number
BR9908765A
BR9908765A BR9908765-0A BR9908765A BR9908765A BR 9908765 A BR9908765 A BR 9908765A BR 9908765 A BR9908765 A BR 9908765A BR 9908765 A BR9908765 A BR 9908765A
Authority
BR
Brazil
Prior art keywords
phe
peptide
preparation
ala
tetrapeptide
Prior art date
Application number
BR9908765-0A
Other languages
Portuguese (pt)
Inventor
Henry Franzen
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BR9908765A publication Critical patent/BR9908765A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1027Tetrapeptides containing heteroatoms different from O, S, or N

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"PROCESSO PARA A PREPARAçãO DO TETRAPEPTìDEO H-TYR-D-ALA-PHE(F)-PHE-NH~ 2~, PEPTìDEO, E DERIVADO DE PEPTìDEO" A presente invenção expõe um processo novo e aperfeiçoado para a preparação do tetrapeptídeo H-Tyr-D-Ala-Phe(F)-Phe-NH~ 2~, que é um peptídeo de fórmula (I): ou um sal farmaceuticamente aceitável do mesmo, assim como novos intermediários na preparação dos mesmos. O novo processo é adequado para a produção em larga escala."PROCESS FOR THE PREPARATION OF THE H-TYR-D-ALA-PHE (F) -PHE-NH ~ 2 ~, PEPTIDE, AND PEPTIDE DERIVATIVE TETRAPEPTIDE" The present invention exposes a new and improved process for the preparation of the H- tetrapeptide Tyr-D-Ala-Phe (F) -Phe-NH ~ 2 ~, which is a peptide of formula (I): or a pharmaceutically acceptable salt thereof, as well as new intermediates in the preparation thereof. The new process is suitable for large-scale production.

BR9908765-0A 1998-03-16 1999-03-16 Process for the preparation of the tetrapeptide h-tyr-d-ala-phe (f) -phe-nh2, peptide, and peptide derivative BR9908765A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9800865A SE9800865D0 (en) 1998-03-16 1998-03-16 New Process
PCT/SE1999/000414 WO1999047548A1 (en) 1998-03-16 1999-03-16 Process for the preparation of a tetrapeptide

Publications (1)

Publication Number Publication Date
BR9908765A true BR9908765A (en) 2000-11-07

Family

ID=20410566

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908765-0A BR9908765A (en) 1998-03-16 1999-03-16 Process for the preparation of the tetrapeptide h-tyr-d-ala-phe (f) -phe-nh2, peptide, and peptide derivative

Country Status (19)

Country Link
EP (1) EP1062231A1 (en)
JP (1) JP2002506880A (en)
KR (1) KR20010041888A (en)
CN (1) CN1300293A (en)
AU (1) AU2968899A (en)
BR (1) BR9908765A (en)
CA (1) CA2323678A1 (en)
EE (1) EE200000540A (en)
HU (1) HUP0102877A3 (en)
ID (1) ID26938A (en)
IL (1) IL138244A0 (en)
IS (1) IS5612A (en)
NO (1) NO20004613L (en)
PL (1) PL343277A1 (en)
SE (1) SE9800865D0 (en)
SK (1) SK13442000A3 (en)
TR (1) TR200002652T2 (en)
WO (1) WO1999047548A1 (en)
ZA (1) ZA200004376B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903291D0 (en) * 1999-09-15 1999-09-15 Astra Ab New process
ES2550604T3 (en) * 2007-12-13 2015-11-11 Cytogel Pharma, Llc Advantageous salts of opioid receptor peptides mu
CN103319568B (en) * 2013-06-20 2015-01-21 重庆理工大学 Non-protein amino acid antibacterial peptide and application for same
CN104371002B (en) * 2013-06-20 2017-10-10 重庆理工大学 A kind of non-protein amino acid antibacterial peptide and its application
CN104478993B (en) * 2013-06-20 2017-10-10 重庆理工大学 A kind of non-protein amino acid antibacterial peptide and its application
CN104783298A (en) * 2015-03-24 2015-07-22 湖州珍贝羊绒制品有限公司 Preparation and application of biological sterilizing composition and nanoemulsion thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9503924D0 (en) * 1995-08-18 1995-11-07 Astra Ab Novel opioid peptides
GB9516994D0 (en) * 1995-08-18 1995-10-18 Iaf Biochem Int Solution synthesis of peripheral acting analgestic opioid tetrapeptides

Also Published As

Publication number Publication date
WO1999047548A1 (en) 1999-09-23
EP1062231A1 (en) 2000-12-27
EE200000540A (en) 2002-02-15
ZA200004376B (en) 2001-10-31
SE9800865D0 (en) 1998-03-16
ID26938A (en) 2001-02-22
HUP0102877A2 (en) 2002-01-28
IS5612A (en) 2000-08-30
IL138244A0 (en) 2001-10-31
NO20004613L (en) 2000-10-30
SK13442000A3 (en) 2001-04-09
AU2968899A (en) 1999-10-11
CN1300293A (en) 2001-06-20
PL343277A1 (en) 2001-08-13
KR20010041888A (en) 2001-05-25
CA2323678A1 (en) 1999-09-23
JP2002506880A (en) 2002-03-05
HUP0102877A3 (en) 2002-02-28
TR200002652T2 (en) 2000-11-21
NO20004613D0 (en) 2000-09-15

Similar Documents

Publication Publication Date Title
BR0312729A (en) New indole-3-sulfur derivatives
BR0113776A (en) Composition of selected fused pyrrolocarbazoles and method for treating and preventing various diseases using said composition
BG106685A (en) Using of fumaric acid derivatives for treating mitochondrial diseases
BRPI0416216A (en) glycoimidazole and polyhydroxycyclohexenyl compound and method for synthesizing glycoimidazole and polyhydroxycyclohexenyl compound, methods for inhibiting glucocerebrosidase, for enhancing glucocerebrosidase activity, pharmaceutical composition, methods for inhibiting a -glycosity, and for treating gaucher disease, glycoimidazole and polyhydroxycyclohexylamine derivatives
BR0109854A (en) Process for the production of perciquinine and its use as a pharmaceutical
BR0306724A (en) amino substituted carboxamides for treatment of alzheimer's disease
BR9808953A (en) Compound, process to treat a cyclooxygenase-2 mediated disorder in a patient, and pharmaceutical composition
BRPI0409624A (en) Benzamide 2-hydroxy-3-diaminoalkanes
BR0111980A (en) Substituted amine, protected compound, methods for treating a patient having or preventing a patient from contracting a disease or condition, inhibiting beta-secretase activity, inhibiting cleavage of amyloid precursor protein (app), inhibiting Production of the beta amyloid peptide (a beta) in a cell, to inhibit beta0amyloid plaque production in an animal, and to treat or prevent a disease comprising beta-amyloid deposits in the brain, composition method for producing a beta-secretase complex , assembly, and use of substituted amine
BR0211122A (en) Compound, methods for treating or preventing disease and for making a compound, intermediate, and use of a compound or salt
BR0010555A (en) Neuraminidase Inhibitors
BR0112395A (en) Benzothiazole Derivatives
AR022469A1 (en) USE OF SUBSTITUTED AND DERIVATIVE ISOXAZOLCARBOXILIC ACIDS AND NEW SUBSTANCES
BR0314611A (en) Thiazole compounds for the treatment of neurodegenerative disorders
BR0109836A (en) Synthesis process of perindopril and its pharmaceutically acceptable salts
BR0013311A (en) Substituted 1,5-dihydropyrrol-2-one derivatives effective as nmda receptor antagonists for the treatment of pain states
BRPI0409465A (en) carboxamide derivatives as antidiabetic agents
SE9903291D0 (en) New process
ES2171559T3 (en) AGENT TO POTENTIATE THE ACTIVITY OF THE NERVOUS GROWTH FACTOR CONTAINING A 1,2-ETHANODIOL DERIVATIVE OR A SALT OF THE SAME.
BR0114697A (en) Piperazine bridge derivatives
BR9908765A (en) Process for the preparation of the tetrapeptide h-tyr-d-ala-phe (f) -phe-nh2, peptide, and peptide derivative
BR0111933A (en) Use of pamic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterized by deposits of amyloid aggregates
BR0014461A (en) Compound and method for preparing the same
BR9807988A (en) Process for the preparation of a compound, e, compound.
BR9812085A (en) "method for the synthesis of quinoline derivatives"

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTA A 6O, 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.